SCHOTT Pharmaceutical creates solutions based on scientific principles to ensure the safety and user-friendliness of medications for individuals globally, as the well-being of people is of great importance. The product line includes containment and delivery solutions for injectable medications, which range from prefilled glass and polymer syringes to cartridges, vials, and ampoules. SCHOTT Pharma employs a diverse team of approximately 4,700 individuals from more than 65 different countries, who are dedicated to advancing global healthcare. The company has a presence in major pharmaceutical centers, with 16 manufacturing facilities in Europe, North and South America, and Asia. With over 1,000 patents and proprietary technologies, the company has established a cutting-edge research and development center in Switzerland, and around 130 R&D professionals are focused on creating innovations for the future. SCHOTT Pharma AG & Co. KGaA, with its headquarters in Mainz, Germany, is a part of SCHOTT AG, which is under the ownership of the Carl Zeiss Foundation. In line with this ethos, SCHOTT Pharma is committed to promoting sustainable development for society and the environment, with the strategic aim of achieving climate neutrality by 2030.